The combination of tucatinib and trastuzumab received accelerated approval from the FDA to treat adults with RAS wild-type, HER2-positive unresectable or metastatic colorectal cancer (mCRC) that advances after treatment with specific types of chemotherapy.
A small study conducted in China suggests pregnant women with idiopathic pulmonary arterial hypertension (iPAH) are at higher risk of maternal mortality compared with women with certain other types of pulmonary hypertension (PH).
Frequent visits to green spaces may be associated with lower use of asthma, mental health, and high blood pressure medication in urban environments.
A perspective article discussed the possible approaches that scientists can take in developing a new generation of vaccines to fight against several respiratory viruses.
Johnson & Johnson (J&J) ends late-stage HIV vaccine trial; mothers in states with abortion bans are almost 3 times more likely to die before, during, and after birth; Sanofi hopes to release a drug for hemophilia A in 2023.
A Q-TWiST analysis of ZUMA-7 trial data suggests that axicabtagene ciloleucel (axi-cel) in the second line is beneficial to quality-adjusted survival and is a viable option for patients with relapsed or refractory large B-cell lymphoma after first-line chemoimmunotherapy.
A review explored clinical considerations related to the pathogenesis, diagnosis, and management of idiopathic hypersomnia.
Pretreatment interstitial lung abnormalities were associated with worse overall and cause-specific survival in Japanese patients receiving chemoradiotherapy followed by adjuvant durvalumab for locally advanced non–small-cell lung cancer.
This new investigation serves to update decades-old data on patient eligibility for and participation in cardiac rehabilitation programs.
Patients with chronic obstructive pulmonary disease (COPD) are more likely to die in the year after undergoing surgery and rack up higher health care costs post-operation, study finds.
The new National Comprehensive Cancer Network (NCCN) forum on equity aims to improve diversity of clinical staff representation across the nation’s leading academic cancer centers.
A preplanned analysis of the PACIFIC-R confirms findings from the pivotal PACIFIC trial of durvalumab as consolidation therapy in unresectable NSCLC after chemoradiotherapy.
The ability to screen for trauma symptoms in certain high-risk populations could soon benefit from biomarker data gathered through wearable devices, according to a new study.
CMS released accountable care organization (ACO) 2023 data; Chinese Lunar New Year travel threatens a COVID-19 toll in China; nursing homes to be audited for inappropriate antipsychotic drug usage.
A study found that screening for spinal muscular atrophy (SMA) in newborns paired with early access to disease-modifying therapies was effective in alleviating the burden and comorbidities of the disease.
Using data from the UK Biobank, potential correlations were investigated between excessive skin scarring outcomes arising from comorbidities among 230,000-plus European individuals.
Secondhand cannabis smoke (SCS) may be contributing to an increase in asthma among children and teens in states where recreational cannabis is legal.
This experimental research suggests the expression levels of certain genes might help explain why people with lung cancer often have more severe cases of COVID-19.
The reality of a sickle cell disease cure brings fear, optimism, and questions to patients’ lives; veterans who are in suicidal crisis can receive free emergency care at any Department of Veterans Affairs or private facility; Pfizer to increase access to progressive treatments through sale of drugs at non-profit prices to poor countries.
No difference in treatment efficacy was observed between intranasal mometasone furoate and saline for the management of sleep-disordered breathing (SDB) symptoms in children, with findings indicating that almost one-half of children with SDB could be initially managed in the primary care setting.
Female patients and people younger than 18 years were particularly sensitive to pollution levels, this study found.
Patients who received nirmatrelvir plus ritonavir (Paxlovid) had lower risk of both hospitalization within 14 days and death within 28 days compared with patients who did not receive the treatment.
Access to electronic health information can be improved through provider assistance for optimal use of a patient portal.
The most common symptoms of long COVID include fatigue, anxiety and depression, shortness of breath, sleep disturbances, and heart palpitations.
The utility of and adherence to follow-up exams for potential recurrence of chronic rhinosinusitis with nasal polyps (CRSwNP) was investigated among 60 patients who had undergone functional endoscopic sinus surgery.
A new study has found that vaccine effectiveness against infection after 4 doses of the COVID-19 vaccine disappeared after 90 days for Omicron variants BA.2, BA.2.12.1, BA.4, and BA.5, although it remained effective against hospitalizations.
Patients who took hydroxychloroquine had an overall risk of hydroxychloroquine retinopathy of 8.6% after 15 years.
This new report shows people who used the digital therapeutic saw an improvement of 14% to 15% in their average blood glucose levels regardless of their racial or ethnic category.
The findings on tumor mutational burden (TMB) may fill a gap in biomarkers for patients who have non–small cell lung cancer (NSCLC).
